Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2026-01-28 @ 9:08 PM
Study NCT ID:
NCT06057402
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2023-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Sponsor:
Organization: